Suppr超能文献

在采用移植后环磷酰胺的大规模单倍体造血干细胞移植中,严重感染和感染相关死亡率。

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.

机构信息

Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Jose Carreras Leukemia Research Institutes, Universitat Autonoma of Barcelona, Barcelona, Spain.

Hematology Department, Hospital Regional Universitario, Malaga, Spain.

出版信息

Bone Marrow Transplant. 2021 Oct;56(10):2432-2444. doi: 10.1038/s41409-021-01328-4. Epub 2021 May 31.

Abstract

Severe infections and their attributable mortality are major complications in recipients of allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult patients who received haploSCT with PTCy. The median follow-up for survivors was 37 months. The overall incidence of bloodstream infections by gram-positive and gram-negative bacteria at 37 months was 51% and 46%, respectively. The incidence of cytomegalovirus infection was 69%, while Epstein Barr virus infections occurred in 10% of patients and hemorrhagic cystitis in 35% of cases. Invasive fungal infections occurred in 11% at 17 months. The 3-year incidence of infection-related mortality was 19%. The median interval from transplant to IRM was 3 months (range 1-30), 53% of IRM occurred >100 days post-haploSCT. Risk factors for IRM included age >50 years, lymphoid malignancy, and developing grade III-IV acute GvHD. Bacterial infections were the most common causes of IRM (51%), mainly due to gram-negative bacilli BSI. In conclusion, severe infections are the most common causes of NRM after haploSCT with PTCy, with a reemergence of gram-negative bacilli as the most lethal pathogens. More studies focusing on the severe infections after haploSCT with PTCy and differences with other types of alloSCT in adults are clearly warranted.

摘要

严重感染及其相关死亡率是异基因造血干细胞移植(alloSCT)受者的主要并发症。我们在此报告了 236 例接受 PTCy 单倍体造血干细胞移植的成年患者。幸存者的中位随访时间为 37 个月。37 个月时,血流感染革兰阳性菌和革兰阴性菌的总发生率分别为 51%和 46%。巨细胞病毒感染的发生率为 69%,而 EBV 感染发生率为 10%,出血性膀胱炎发生率为 35%。侵袭性真菌感染在 17 个月时的发生率为 11%。3 年感染相关死亡率为 19%。从移植到 IRM 的中位时间为 3 个月(范围 1-30),53%的 IRM 发生在单倍体造血干细胞移植后>100 天。IRM 的危险因素包括年龄>50 岁、淋巴恶性肿瘤和发生 3-4 级急性移植物抗宿主病。细菌感染是 IRM 的最常见原因(51%),主要是由于革兰氏阴性菌菌血症。总之,在接受 PTCy 单倍体造血干细胞移植后,严重感染是导致 NRM 的最常见原因,革兰氏阴性菌再次成为最致命的病原体。显然,需要更多的研究来关注 PTCy 单倍体造血干细胞移植后严重感染以及与成人其他类型 alloSCT 的差异。

相似文献

5
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching.
Biol Blood Marrow Transplant. 2020 Jun;26(6):1179-1188. doi: 10.1016/j.bbmt.2020.01.013. Epub 2020 Jan 28.

引用本文的文献

3
Blood Virome After Allogeneic Hematopoietic Stem Cell Transplantation.
Open Forum Infect Dis. 2025 Apr 10;12(4):ofaf213. doi: 10.1093/ofid/ofaf213. eCollection 2025 Apr.
7
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Nat Commun. 2024 Dec 3;15(1):10339. doi: 10.1038/s41467-024-54595-2.
8
Outcomes in hematopoetic cell transplantation in the setting of mold infections in patients with chronic granulomatous disease.
Bone Marrow Transplant. 2025 Feb;60(2):191-200. doi: 10.1038/s41409-024-02389-x. Epub 2024 Nov 4.

本文引用的文献

4
Immune reconstitution after T-cell replete HLA-haploidentical transplantation.
Semin Hematol. 2019 Jul;56(3):221-226. doi: 10.1053/j.seminhematol.2019.03.005. Epub 2019 Mar 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验